NCT02692781View on ClinicalTrials.gov

A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 15, 2016

Study Completion Date

December 15, 2016

Conditions
Obesity
Interventions
DRUG

MOD-6031

OTHER

Placebo control

Trial Locations (1)

64239

Tel Aviv Sourasky Medical Center, Tel Aviv

All Listed Sponsors
collaborator

Tel-Aviv Sourasky Medical Center

OTHER_GOV

lead

OPKO Health, Inc.

INDUSTRY

NCT02692781 - A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects | Biotech Hunter | Biotech Hunter